Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,573,983
-$454,529 QoQ
Shares Held
106,893
-0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#855
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. PFE ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
This page
|
106,893 | $2,573,983 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,573,983 | 106,893 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,028,512 | 107,853 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,697,417 | 108,330 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,832,866 | 111,180 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $2,767,044 | 114,152 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,992,831 | 118,107 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,345,247 | 126,093 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $3,776,698 | 130,501 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,690,058 | 131,882 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $3,785,821 | 136,426 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $4,627,157 | 160,721 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $6,631,014 | 199,910 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $16,182,152 | 441,171 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $18,455,798 | 452,348 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $23,071,476 | 450,263 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $20,108,726 | 459,523 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $22,452,046 | 428,229 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $22,209,847 | 429,010 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $24,415,108 | 413,465 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $17,583,520 | 408,824 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,466,320 | 394,952 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $13,934,601 | 384,615 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,806,493 | 347,908 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $11,555,534 | 314,865 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,174,713 | 280,572 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,017,156 | 245,624 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||